All Updates

Statement from American Cancer Society Cancer Action Network (ACS CAN) Regional Government Relations Director Emily Ogden NASHVILLE, TENN. – “Musicians and hospitality workers are some of the only Tennesseans who are not guaranteed a smoke-free workplace due to an exemption in the Nonsmokers’ Protection Act of 2008. Today

HARTFORD – Today lawmakers in the appropriations committee released their proposed budget for the State of Connecticut. After years of zero dollars being allocated for lifesaving tobacco control programs, today’s budget includes $12 million for the Tobacco and Health trust Fund. The following statement can be attributed to Bryte

ACS CAN volunteers met virtually with state lawmakers and urged them to pass legislation that would ensure comprehensive biomarker testing is covered by more insurance plans. Biomarker testing is critical in accessing precision medicine, which can lead to improved survivorship and better quality of life for cancer patients.

Today the administration released a proposed rule that would fix the so-called ‘family glitch’ in the Affordable Care Act.

Today the administration released a proposed rule that would fix the so-called ‘family glitch’ in the Affordable Care Act.

ACS CAN volunteers met virtually with state lawmakers and urged them to pass legislation that would ensure comprehensive biomarker testing is covered by more insurance plans. Biomarker testing is critical in accessing precision medicine, which can lead to improved survivorship and better quality of life for cancer patients.

National Cancer Institute (NCI) director, Dr. Ned Sharpless, has announced he intends to leave his post at NCI at the end of April. Dr. Sharpless has led the Institute for five years during which time he proved to be a tireless advocate for increased investment in cancer research.

ATLANTA, GA – April 4, 2022 – As of late Friday evening, the House and Senate respectively passed a resolution recognizing the benefits of biomarker testing , marking a key step in accessing precision medicine treatments, and increasingly important in the treatment

National Cancer Institute (NCI) director, Dr. Ned Sharpless, has announced he intends to leave his post at NCI at the end of April. Dr. Sharpless has led the Institute for five years during which time he proved to be a tireless advocate for increased investment in cancer research.